Artivion | CRY - Capitale Sociale E Riserve





Capitale Sociale E Riserve Cambiamento Data
Abbott USD 52.06B 69M 2026-03
Accuray USD 53.42M 8.45M 2025-12
AngioDynamics USD 176.33M 2.52M 2025-09
Artivion USD 445.58M 4.88M 2026-06
AtriCure USD 516.43M 24.74M 2026-06
Baxter International USD 6.21B 163M 2026-06
Becton, Dickinson and Co. USD 24.42B 283M 2026-06
Boston Scientific USD 24.93B 934M 2026-06
Edwards Lifesciences USD 10.62B 290.5M 2026-06
Inogen USD 197.18M 2.32M 2025-09
Integra LifeSciences USD 1.04B 971K 2026-06
J&J USD 84.97B 3.78B 2026-06
Mesa Laboratories USD 186.69M 8.22M 2025-12
Orthofix International USD 429.18M 6.01M 2026-06
Pfizer USD 85.19B 4.91B 2026-06
ResMed USD 6.59B 93.48M 2026-06
Stryker USD 22.98B 559M 2026-03
Tandem Diabetes Care USD 130.39M 2.02M 2026-06
Teleflex USD 2.9B 179.9M 2026-06
Terumo JPY 1.66T 77.51B 2026-06
Trinity Biotech USD -71.98M 17.26M 2025-12